v3.26.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Aug. 31, 2026
Aug. 31, 2025
Cash flows from operating activities:    
Net income $ 126,053 $ 327,268
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Equity in income of unconsolidated joint ventures (12,995) (18,447)
Distributions of earnings from unconsolidated joint ventures 12,993 27,741
Amortization of debt issuance costs 3,171 2,686
Depreciation and amortization 31,094 27,440
Gain on sale of investment (3,528) 0
Stock-based compensation 11,298 25,131
Inventory impairments and land option contract abandonments 10,720 18,351
Changes in assets and liabilities:    
Receivables (32,739) 7,166
Inventories (326,481) (330,019)
Accounts payable, accrued expenses and other liabilities (49,191) (63,835)
Other, net 725 8,358
Net cash provided by (used in) operating activities (228,880) 31,840
Cash flows from investing activities:    
Contributions to unconsolidated joint ventures (19,422) (10,593)
Return of investments in unconsolidated joint ventures 16,557 2,965
Proceeds from sale of investment 20,028 0
Purchases of property and equipment, net (32,510) (34,609)
Net cash used in investing activities (15,347) (42,237)
Cash flows from financing activities:    
Borrowings under revolving credit facility 900,000 555,000
Repayments under revolving credit facility (485,000) (305,000)
Payments on mortgages and land contracts due to land sellers and other loans (641) 0
Issuance of common stock under employee stock plans 5,688 652
Stock repurchases and excise taxes paid (180,123) (438,460)
Tax payments associated with stock-based compensation awards (18,336) (15,884)
Payments of cash dividends (47,746) (52,806)
Net cash provided by (used in) financing activities 173,842 (256,498)
Net decrease in cash and cash equivalents (70,385) (266,895)
Cash and cash equivalents at beginning of period 230,443 599,193
Cash and cash equivalents at end of period $ 160,058 $ 332,298